MYL6 and Sepsis: Both in vivo and in vitro results were consistent, indicating higher ACSL4 and MYL6 mRNA levels in LPS-induced septic mice and cells, suggesting that ACSL4 and MYL6 may be potential therapeutic targets for sepsis-induced ALI.